USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Chromotrax, Inc.
Address:
Chromotrax, Inc.
2000 N 14Th St, Ste 530
Arlington, VA 22201 0250
Phone:
(703) 558-3400
URL:
N/A
EIN:
542021057
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
Yes
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $331,813.00 3
SBIR Phase II $749,999.00 1

Award List:

Structural Component Substantiation Methodology

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$99,998.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Joe Lucas, Principal Investigator
Abstract:
We propose a breakthrough technique for ultra rapid, sensitive detection of cancer specific chromosome rearrangements in solution to facilitate bulk quantification of tumor cells for early detection of metastatic tumor cells in bone marrow, lymph nodes,and peripheral blood. Combining two separate,… More

Development of Serum Based Biomarker for the Detection of Cancer

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Joe Lucas, Principal Investigator
Abstract:
"We propose an innovative technique for ultra rapid, sensitive detection ofcancer specific chromosome rearrangements in solution to facilitate bulkquantification of aberrant chromosomes for early detection of metastatictumor cells. (I) We will apply DNA hybridization in suspension to humanbreast… More

Development of Serum Based Biomarker for the Detection of Cancer

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$749,999.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Joe Lucas, Principal Investigator
Abstract:
"We propose an innovative technique for ultra rapid, sensitive detection ofcancer specific chromosome rearrangements in solution to facilitate bulkquantification of aberrant chromosomes for early detection of metastatictumor cells. (I) We will apply DNA hybridization in suspension to humanbreast… More

Innovative molecular cytogenetic techniques for early leukemia/lymphoma detection

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$231,815.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We propose an innovative approach combining two separate, novel techniques to greatly enhance accurate detection of leukemia or lymphoma cells, which can be used ultimately for diagnostics and early detection of minimal residual disease (MRD) in bone marrow,… More